The European Commission and Italy have blocked a shipment of AstraZeneca's COVID-19 vaccine destined for Australia after the pharmaceutical company did not fulfil its European Union contract commitments, sources said on Thursday.
It is the first time the EU has employed an export control mechanism it set up to ensure drug manufacturers respect their contracts.
The sources said AstraZeneca had reportedly requested authorization from the Italian government to export some 250,000 doses from its Anagni plant, close to Rome. The site is owned by US group Catalent.
No comments:
Post a Comment